fungal infection, stem cell transplantation, prophylaxis
Showing 1 - 25 of >10,000
Fungal Infection Trial in Shanghai (Escalating prophylaxis)
Recruiting
- Fungal Infection
- Escalating prophylaxis
-
Shanghai, Shanghai, ChinaBlood & Marrow Transplantation Center, RuiJin Hospital
Nov 23, 2021
Posaconazole for Pulmonary Fungal Infection Prophylaxis in
Not yet recruiting
- Pulmonary Fungal Infection
- Oral Posaconazole tablets
-
Shijia Zhuang, China
- +3 more
Jan 22, 2021
Dose Optimization of Caspofungin in Adolescents
Completed
- Invasive Fungal Infections
-
Wuhan, ChinaWuhan Children's Hospital
May 28, 2023
The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After
Not yet recruiting
- The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
- (no location specified)
Jun 13, 2023
To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation Trial (Letermovir for secondary prophylaxis)
Not yet recruiting
- To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
- Letermovir for secondary prophylaxis
- (no location specified)
Jun 13, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Allogeneic Hematopoietic Stem Cell Trial in New York (fecal microbiota transplantation (FMT), No fecal microbiota
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell
- fecal microbiota transplantation (FMT)
- No fecal microbiota transplantation (FMT), routine management
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 25, 2022
Letermovir Prophylaxis for CMV Infection in Haplo-HSCT
Recruiting
- CMV Infection
- Hematopoietic Stem Cell Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Mar 29, 2023
Hematological Malignancy Trial (Thymoglobulin Injectable Product)
Not yet recruiting
- Hematological Malignancy
- Thymoglobulin Injectable Product
- (no location specified)
Sep 27, 2023
Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)
Not yet recruiting
- Allogeneic Disease
- +2 more
- WJ-MSC infusion
- (no location specified)
May 4, 2023
Hematologic Malignancy, Myeloproliferative Disorder Trial in New York (Isavuconazole)
Completed
- Hematologic Malignancy
- Myeloproliferative Disorder
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 15, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Opportunistic Fungal Infection, Opportunistic Viral Infection, Bone Marrow Transplant Infection Trial in Patra, Thessaloníki
Recruiting
- Opportunistic Fungal Infection
- +2 more
- Pentavalent-specific T cells (penta-STs)
-
Patra, Greece
- +1 more
Jul 26, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Letermovir)
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- Letermovir
- (no location specified)
Jan 23, 2023
Donor COVID-19 Infection Status on the Recipient in Allo-HSCT
Recruiting
- COVID-19
- Hematopoietic Stem Cell Transplantation
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital of Soochow University
Jan 10, 2023
Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell
Not yet recruiting
- Cytomegaloviral Infection
- Hematopoietic and Lymphoid System Neoplasm
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 16, 2022
Microbial Colonization Trial in Atlanta (Rifaximin)
Completed
- Microbial Colonization
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Oct 8, 2021
The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA Trial (Ruxolitinib 5 MG BID Oral Tablet)
Not yet recruiting
- The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
- Ruxolitinib 5 MG BID Oral Tablet
- (no location specified)
Jun 13, 2023
Fungal Infection, Hematopoietic and Lymphoid Cell Tumor Trial in Canada, United States (Caspofungin Acetate, Fluconazole,
Completed
- Fungal Infection
- Hematopoietic and Lymphoid Cell Neoplasm
- Caspofungin Acetate
- +3 more
-
Phoenix, Arizona
- +48 more
Jan 24, 2022
Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute
Not yet recruiting
- Peripheral Blood Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Melphalan
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Immune Reconstitution to CMV After HSCT: Impact of Clinical
Enrolling by invitation
- CMV Infection
- Hematopoietic Stem Cell Transplantation
-
Beijing, Beijing, China
- +1 more
Jan 5, 2023
Stem Cell Transplant Complications, Central Venous Catheter Exit Site Infection Trial in Ankara (CENTRAL VENOUS CATHETER CARE
Recruiting
- Stem Cell Transplant Complications
- Central Venous Catheter Exit Site Infection
- CENTRAL VENOUS CATHETER CARE PROTOCOL
-
Ankara, TurkeyHealth Science University Gülhane Training and Research Hospital
Jan 27, 2023
Lymphoma, Leukemia Trial (Acalabrutinib, tacrolimus, methotrexate)
Withdrawn
- Lymphoma
- Leukemia
- Acalabrutinib, tacrolimus, methotrexate
- (no location specified)
Feb 20, 2022
Intestinal Microbiome Dynamics in Solid Organ and Stem Cell
Enrolling by invitation
- Transplantation Infection
- +4 more
- Intestinal microbiome new generation sequencing
-
Minsk, BelarusMinsk Scientific-Practical Center for Surgery, Transplantation a
Aug 28, 2022